Vitamins and perinatal outcomes among HIV-negative women in Tanzania

被引:140
作者
Fawzi, Wafaie W.
Msamanga, Gernard I.
Urassa, Willy
Hertzmark, Ellen
Petraro, Paul
Willett, Walter C.
Spiegelman, Donna
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Muhimbili Univ, Coll Hlth Sci, Dept Community Hlth, Dar Es Salaam, Tanzania
[5] Muhimbili Univ, Coll Hlth Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania
关键词
D O I
10.1056/NEJMoa064868
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Prematurity and low birth weight are associated with high perinatal and infant mortality, especially in developing countries. Maternal micronutrient deficiencies may contribute to these adverse outcomes. METHODS In a double-blind trial in Dar es Salaam, Tanzania, we randomly assigned 8468 pregnant women (gestational age of fetus, 12 to 27 weeks) who were negative for human immunodeficiency virus infection to receive daily multivitamins (including multiples of the recommended dietary allowance) or placebo. All the women received prenatal supplemental iron and folic acid. The primary outcomes were low birth weight (<2500 g), prematurity, and fetal death. RESULTS The incidence of low birth weight was 7.8% among the infants in the multivitamin group and 9.4% among those in the placebo group (relative risk, 0.82; 95% confidence interval [CI], 0.70 to 0.95; P=0.01). The mean difference in birth weight between the groups was modest (67 g, P<0.001). The rates of prematurity were 16.9% in the multivitamin group and 16.7% in the placebo group (relative risk, 1.01; 95% CI, 0.91 to 1.11; P=0.87), and the rates of fetal death were 4.3% and 5.0%, respectively (relative risk, 0.87; 95% CI, 0.72 to 1.05; P=0.15). Supplementation reduced both the risk of a birth size that was small for gestational age (<10th percentile; 10.7% in the multivitamin group vs. 13.6% in the placebo group; relative risk, 0.77; 95% CI, 0.68 to 0.87; P<0.001) and the risk of maternal anemia (hemoglobin level, <11 g per deciliter; relative risk, 0.88; 95% CI, 0.80 to 0.97; P=0.01), although the difference in the mean hemoglobin levels between the groups was small (0.2 g per deciliter, P<0.001). CONCLUSIONS Multivitamin supplementation reduced the incidence of low birth weight and small-for-gestational-age births but had no significant effects on prematurity or fetal death. Multivitamins should be considered for all pregnant women in developing countries. (ClinicalTrials.gov number, NCT00197548.).
引用
收藏
页码:1423 / 1431
页数:9
相关论文
共 31 条
[11]  
Hughes MD, 1995, AIDS CLIN TRIALS, P177
[12]  
Humphrey JH, 2006, J INFECT DIS, V193, P960
[13]   Effects of prenatal multimicronutrient supplements on birth weight and perinatal mortality:: a randomised, controlled trial in Guinea-Bissau [J].
Kæstel, P ;
Michaelsen, KF ;
Aaby, P ;
Friis, H .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2005, 59 (09) :1081-1089
[14]  
Lumley J., 2001, Cochrane Database Syst. Rev., DOI [DOI 10.1002/14651858.CD001056, 10.1002/14651858.CD001056.pub2]
[15]   Influence of maternal nutrition on outcome of pregnancy: prospective cohort study [J].
Mathews, F ;
Yudkin, P ;
Neil, A .
BRITISH MEDICAL JOURNAL, 1999, 319 (7206) :339-343
[16]   THE CONTRIBUTION OF LOW BIRTH-WEIGHT TO INFANT-MORTALITY AND CHILDHOOD MORBIDITY [J].
MCCORMICK, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (02) :82-90
[17]   Iron supplementation in pregnancy [J].
Müngen, E .
JOURNAL OF PERINATAL MEDICINE, 2003, 31 (05) :420-426
[18]   Low maternal vitamin B12 status is associated with intrauterine growth retardation in urban South Indians [J].
Muthayya, S. ;
Kurpad, A. V. ;
Duggan, C. P. ;
Bosch, R. J. ;
Dwarkanath, P. ;
Mhaskar, A. ;
Mhaskar, R. ;
Thomas, A. ;
Vaz, M. ;
Bhat, S. ;
Fawzi, W. W. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2006, 60 (06) :791-801
[19]  
Osendarp SJM, 2003, J NUTR, V133, p817S
[20]   Effects of antenatal multiple micronutrient supplementation on birthweight and gestational duration in Nepal: double-blind, randomised controlled trial [J].
Osrin, D ;
Vaidya, A ;
Shrestha, Y ;
Baniya, RB ;
Manandhar, DS ;
Adhikari, RK ;
Filteau, S ;
Tomkins, A ;
Costello, AMD .
LANCET, 2005, 365 (9463) :955-962